News - Otsuka, Antibiotics and Infectious diseases

Filter

Popular Filters

1 to 25 of 281 results

Joint purchasing of vaccines and medicines becomes a reality in the EU

Joint purchasing of vaccines and medicines becomes a reality in the EU

10-04-2014

The European Commission today approved a Joint Procurement Agreement, which will enable all European…

Antibiotics and Infectious diseasesEuropeFinancialMarkets & MarketingPharmaceuticalVaccines

Tamiflu use called into question by UK report

Tamiflu use called into question by UK report

10-04-2014

The UK government and health policy decision makers are being called upon to review the guidance on the…

Antibiotics and Infectious diseasesChemistryDavid ToveyGlaxoSmithKlineHealthcareMajorPharmaceuticalRelenzaResearchRocheTamifluThe British Medical JournalUKUK government

Alkermes leaps on positive Ph III results for aripiprazole lauroxil for schizophrenia

Alkermes leaps on positive Ph III results for aripiprazole lauroxil for schizophrenia

09-04-2014

US biotech firm Alkermes saw its shares spike on Tuesday, after it announced positive top-line results…

AbilifyAlkermesaripiprazole lauroxilBiotechnologyLundbeckNeurologicalOtsukaRegulationResearch

Abilify Maintena cuts hospitalization rates for patients with schizophrenia vs oral antipsychotics

07-04-2014

Danish CNS drug specialist Lundbeck and partner Japanese drugmaker Otsuka Pharmaceutical today announced…

Abilify MaintenaLundbeckNeurologicalOtsukaPharmaceuticalResearch

Promising future for Cubist's Sivextro in anti-MRSA sector

04-04-2014

Following its launch, Cubist Pharmaceutical’s second generation oxazolidinone Sivextro Sivextro will…

Antibiotics and Infectious diseasesCubist PharmaceuticalsDalvanceDurata TherapeuticsMarkets & MarketingoritavancinPharmaceuticalSivextroThe Medicines Company

Global Fund taps pharmaceutical expertise in China

02-04-2014

The Global Fund is deepening its partnership with China by tapping the expertise of Chinese pharmaceutical…

Anti-viralsAntibiotics and Infectious diseasesChinaGlobalMarkets & MarketingPharmaceuticalProductionRegulation

Unanimous FDA advisory panel backing for Cubist’s Sivextro

Unanimous FDA advisory panel backing for Cubist’s Sivextro

02-04-2014

The US Food and Drug Administration’s Anti-Infective Drugs Advisory Committee on Monday voted unanimously…

Antibiotics and Infectious diseasesCubist PharmaceuticalsNorth AmericaPharmaceuticalRegulationSivextrotedizolidUSA

FDA advisory unanimously recommends Durata’s Dalvance

FDA advisory unanimously recommends Durata’s Dalvance

01-04-2014

The US Food and Drug Anti-Infective Drugs Advisory Committee voted 12 to 0 that Durata Therapeutics’…

Antibiotics and Infectious diseasesDalvanceDermatologicalsDurata TherapeuticsNorth AmericaPharmaceuticalRegulationUSA

Otsuka acquires certain Dacogen and E7727 rights from Eisai

01-04-2014

Otsuka Pharmaceutical has reached an agreement with the US subsidiary of fellow Japanese drugmaker Eisai…

DacogenE7727EisaiLicensingOncologyOtsukaPharmaceutical

Next-generation therapeutics for infectious diseases conquer the global spotlight

25-03-2014

The available antivirals for commonly occurring infections such as respiratory syncytial virus (RSV)…

Antibiotics and Infectious diseasesPharmaceuticalResearch

Otsuka’s Samsca, first ADPKD therapy, approved in Japan

25-03-2014

Japanese drugmaker Otsuka Pharmaceutical says it has become the first company in the world to obtain…

Asia-PacificJapanNephrology and HepatologyOtsukaPharmaceuticalRegulationSamsca

Medimetriks licenses ozenoxacin, a novel antibacterial, from Ferrer

24-03-2014

US specialty drug firm Medimetriks Pharmaceuticals has entered into a licensing agreement with Ferrer,…

Antibiotics and Infectious diseasesFerrer InternacionalLicensingMedimetriks PharmaceuticalsNorth AmericaOzenoxacinPharmaceuticalUSA

Japanese approval for Forxiga and Lonsurf

24-03-2014

Anglo-Swedish drug major AstraZeneca says that Japanese Ministry of Health, Labor and Welfare approved…

Asia-PacificAstraZenecaDiabetesForxigaJapanLonsurfOncologyOno PharmaceuticalOtsukaPharmaceuticalRegulationTaiho Pharmaceutical

India urged to take action on unregulated tuberculosis drug sales

23-03-2014

Although cases of tuberculosis are dropping in Europe, as is the incidence in the USA, an extremely slower…

Antibiotics and Infectious diseasesAsia-PacificHealthcareIndiaPharmaceuticalResearch

Huge disparities in antibiotic consumption across European region, new report shows

Huge disparities in antibiotic consumption across European region, new report shows

20-03-2014

There is an almost fourfold difference between the lowest and the highest antibiotic users among 42 countries…

Antibiotics and Infectious diseasesEuropeMarkets & MarketingPharmaceutical

Incidence of TB down in Europe but multidrug-resistance continues

Incidence of TB down in Europe but multidrug-resistance continues

19-03-2014

Across the 53 countries of the World Health Organization European Region, an estimated 353 000 patients…

Antibiotics and Infectious diseasesEuropeHealthcarePharmaceutical

Clinigen plans to launch Vibativ after lifting of EU marketing authorization suspension

Clinigen plans to launch Vibativ after lifting of EU marketing authorization suspension

18-03-2014

UK specialty pharma company the Clinigen Group today announced that the European Commission has ratified…

Antibiotics and Infectious diseasesClinigen GroupEuropeMarkets & MarketingPharmaceuticalRegulationTelavancin for InjectionUKVibativ

High incidence and inadequate treatments boost prospects of HIV, Chagas, Dengue and influenza H1N1 drugs in Latin America

High incidence and inadequate treatments boost prospects of HIV, Chagas, Dengue and influenza H1N1 drugs in Latin America

17-03-2014

The high incidence of human immunodeficiency virus (HIV), Chagas, dengue and influenza H1N1, as well…

Anti-viralsAntibiotics and Infectious diseasesGenericsMarkets & MarketingPharmaceuticalSouth America

Lundbeck and Otsuka update on European launch of Abilify Maintena

Lundbeck and Otsuka update on European launch of Abilify Maintena

17-03-2014

Danish CNS drug specialist Lundbeck and Japanese drugmaker Otsuka Pharmaceutical’s European subsidiary…

Abilify MaintenaEuropeLundbeckMarkets & MarketingNeurologicalOtsukaPharmaceutical

Taiwan’s TaiGen Biotech receives domestic marketing approval for Taigexyn

13-03-2014

Taiwan-based drug developer TaiGen Biotechnology says that the Taiwan Food and Drug Administration has…

Antibiotics and Infectious diseasesAsia-PacificBiotechnologyRegulationTaiGen BiotechTaigexyn

Mylan pushes further into India, introducing critical care segment

Mylan pushes further into India, introducing critical care segment

12-03-2014

US generics major Mylan says its Indian subsidiary has launched a Critical Care segment in India. The…

AmbisomeAntibiotics and Infectious diseasesAsia-PacificGenericsIndiaMarkets & MarketingMylan Laboratories

Janssen’s Sirturo gets conditional EU approval for multi-resistant TB

Janssen’s Sirturo gets conditional EU approval for multi-resistant TB

10-03-2014

US health care giant Johnson & Johnson’s European subsidiary Janssen-Cilag has been granted conditional…

Antibiotics and Infectious diseasesEuropeJanssen-CilagJohnson & JohnsonPharmaceuticalRegulationSirturo

Argenta and Antabio meet milestone in anti-bacterial drug discovery collaboration

Argenta and Antabio meet milestone in anti-bacterial drug discovery collaboration

10-03-2014

Drug discovery company Argenta, a subsidiary of Belgian drugmaker Galapagos (Euronext: GLPG), has achieved…

Antibiotics and Infectious diseasesArgentaBiotechnologyFranceResearchUK

1 to 25 of 281 results

Back to top